This test detects 84 genes related to gastrointestinal cancer, provides information on targeted drug、chemotherapy、 and hereditary risk assessment.
Gastrointestinal targeted drug gene loci and related pathway genes.
Suggesting targeted drug use and clinical trial information.
Suggesting the efficacy and side effects of chemotherapy drugs for gastrointestinal tumors.
Detect germline variant information, including Lynch syndrome-related genes.
Suggesting pathogenic and suspected pathogenic mutations.
Patients with advanced and newly diagnosed gastrointestinal tumors who need targeted drugs.
Patients with recurrent, drug-resistant gastrointestinal tumors.
Gastrointestinal cancer patients requiring targeted drug therapy via liquid biopsy.